Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction
Clinical Science · 26.04.2023 · 137 (8) · 579-595
DOI: 10.1042/cs20220300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 19.04.2023. Verfasst von Jesrine Hong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mater Research Institute, University of Queensland, Level 3, Aubigny Place, Raymond Terrace, South Brisbane, Queensland 4101, Australia. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Placenta Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fetal growth restriction (FGR) leading to low birth weight (LBW) is a major cause of neonatal morbidity and mortality worldwide. Normal placental development involves a series of highly regulated processes involving a multitude of hormones, transcription factors, and cell lineages. Failure to achieve this leads to placental dysfunction and related placental diseases such as pre-clampsia and FGR. Early recognition of at-risk pregnancies is important because careful maternal and fetal surveillance can potentially prevent adverse maternal and perinatal outcomes by judicious pregnancy surveillance and careful timing of birth. Given the association between a variety of circulating maternal biomarkers, adverse pregnancy, and perinatal outcomes, screening tests based on these biomarkers, incorporating maternal characteristics, fetal biophysical or circulatory variables have been developed. However, their clinical utility has yet to be proven. Of the current biomarkers, placental growth factor and soluble fms-like tyrosine kinase 1 appear to have the most promise for placental dysfunction and predictive utility for FGR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mater Research Institute, University of Queensland, Level 3, Aubigny Place, Raymond Terrace, South Brisbane, Queensland 4101, Australia.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
- School of Medicine, The University of Queensland, Herston, Queensland 4006, Australia.
ORCID-Profile: Sailesh Kumar
Zitieren
APA
Hong, J., & Kumar, S. (2023). Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction. Clinical Science, 137(8), 579-595. https://doi.org/10.1042/cs20220300
Vancouver
Hong J, Kumar S. Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction. Clinical Science. 2023;137(8):579-595. doi:10.1042/cs20220300
BibTeX
@article{Hong2023,
author = {Hong, Jesrine and Kumar, Sailesh},
title = {Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction},
journal = {Clinical Science},
year = {2023},
volume = {137},
number = {8},
pages = {579--595},
doi = {10.1042/cs20220300}
}
EUVIMED